|

Visugromab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CTL-002

Pipeline

Phase 2: 1

Top Sponsors

  • CatalYm GmbH1

Indications

  • Adult Solid Tumor1
  • Metastatic Non-squamous Non Small Cell Lung Cancer1
  • Lung Cancer1
  • Cancer1

Birmingham, Alabama1 trial

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

University of Alabama at Birmingham

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.